- Home
- CRUS vs LNTH Comparison
CRUS vs LNTH Comparison
Compare CRUS & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRUS
- LNTH
- Stock Information
- Founded
- CRUS 1984
- LNTH 1956
- Country
- CRUS United States
- LNTH United States
- Employees
- CRUS N/A
- LNTH N/A
- Industry
- CRUS Semiconductors
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CRUS Technology
- LNTH Health Care
- Exchange
- CRUS Nasdaq
- LNTH Nasdaq
- Market Cap
- CRUS 5.3B
- LNTH 5.7B
- IPO Year
- CRUS 1989
- LNTH 2015
- Fundamental
- Price
- CRUS $105.17
- LNTH $72.43
- Analyst Decision
- CRUS Strong Buy
- LNTH Strong Buy
- Analyst Count
- CRUS 5
- LNTH 5
- Target Price
- CRUS $126.40
- LNTH $131.20
- AVG Volume (30 Days)
- CRUS 429.6K
- LNTH 1.1M
- Earning Date
- CRUS 08-05-2025
- LNTH 08-06-2025
- Dividend Yield
- CRUS N/A
- LNTH N/A
- EPS Growth
- CRUS 22.45
- LNTH N/A
- EPS
- CRUS 6.00
- LNTH 3.53
- Revenue
- CRUS $1,896,077,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- CRUS N/A
- LNTH $4.57
- Revenue Next Year
- CRUS $7.81
- LNTH $9.41
- P/E Ratio
- CRUS $17.46
- LNTH $20.46
- Revenue Growth
- CRUS 5.99
- LNTH 12.53
- 52 Week Low
- CRUS $75.83
- LNTH $69.12
- 52 Week High
- CRUS $147.46
- LNTH $118.21
- Technical
- Relative Strength Index (RSI)
- CRUS 53.13
- LNTH 38.76
- Support Level
- CRUS $99.65
- LNTH $70.40
- Resistance Level
- CRUS $105.48
- LNTH $73.52
- Average True Range (ATR)
- CRUS 2.18
- LNTH 2.67
- MACD
- CRUS -0.18
- LNTH -0.46
- Stochastic Oscillator
- CRUS 68.87
- LNTH 19.02
About CRUS Cirrus Logic Inc.
Cirrus Logic Inc is a provider of integrated circuits for audio and voice signal processing applications. The firm's products are organized into two streams: portable audio products, and HPMS Products. These products include aAmplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, Europe, South Korea, and countries across the world.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.